Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™
New additions advance surgical planning, implant flexibility and connected care across Stryker's Foot & Ankle portfolio Stryker is launching Prophecy® Surgical Planning for the Incompass™ Total Ankle System and introducing Hoffmann®LRF smartHEX™ at the 2026 American Orthopaedic Foot &...
Covered in this story
What has happened since
- Stryker Corporation is up 6.7% since this was published, 34 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Stryker Corporation
- Truist Securities: $278 → $310 by Oct 2027 · Hold via Investing.com
- Needham: $278 → $418 by Oct 2027 · Buy via Investing.com
- Stifel: $275 → $330 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $SYK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Stryker Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.